Registration - Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for participants in exchange for completed activity evaluations. There is no registration fee for this CME activity. If you have previously registered and would like to return to the webcast, please click here.
 

FACULTY DISCLOSURES

KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit

Planners

Jeroen Bax, MD Nothing to Disclose

David Wood, MD – (G/R) Edwards Lifesciences, Medtronic, Abbott Vascular (C/H/S) Edwards Lifesciences

Faculty

Kentaro Hayashida, MD – (G/R) Edwards Lifesciences (C/H/S) Edwards Lifesciences

Sandra Lauck, PhD – (C/H/S) Edwards Lifesciences

Bernard Prendergast, MD –(G/R) Edwards Lifesciences (C/H/S)  Edwards Lifesciences

Athenas Poppas, MD – (C/H/S) GE

Janarthanan Sathananthan, MD – (C/H/S) Edwards Lifesciences; Medtronic; Boston Scientific

 

This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted educational grant provided by Edwards Lifesciences.